A股異動 | 高德紅外逼近漲停創新高 機構稱2020年有望保持高增長
格隆匯1月13日丨高德紅外(002414.SZ)今日股價再次拉昇上漲,漲幅不斷擴大。現大漲9.49%逼近漲停,報27.92元創歷史新高,暫成交4.32億元,最新總市值261.44億元。2019年12月19日至12月31日,公司發佈三個日常經營重要合同公告,合同金額共計超過5億元。本月初中信建投稱,2019年業績創新高,年底新簽訂單奠定2020年高增長基礎,維持“增持”評級。公司拓展了基於紅外探測武器裝備全產業鏈,某武器系統批產在即,未來兩年有望持續放量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.